Akoya Biosciences Inc (NAS:AKYA)
$ 3.22 0.05 (1.58%) Market Cap: 159.39 Mil Enterprise Value: 198.86 Mil PE Ratio: 0 PB Ratio: 7.16 GF Score: 44/100

Q3 2021 Akoya Biosciences Inc Earnings Call Transcript

Nov 08, 2021 / 10:00PM GMT
Release Date Price: $12.91 (-3.01%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2021 Akoya Biosciences Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the conference over to your speaker for today, Priyam Shah. You may begin.

Priyam Shah

Good afternoon, everyone. Thank you for joining us today. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today, we have Brian McKelligon, Chief Executive Officer; and Joe Driscoll, Chief Financial Officer.

Earlier today, Akoya released financial results for the third quarter ended September 30, 2021. A copy of the press release is available on the company's website. Before we begin, I would like to remind you that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot